Analyst consensus rating
MediciNova Analyst Rating: none
Direct answer
MediciNova's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.00.
Forecast evidence checked September 5, 2026.
Get free MediciNova email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.63
- Average price target
- $9.00
- High price target
- $11.00
- Low price target
- $6.00
- Low target gap
- +268.1%
- Target upside
- +452.1%
- High target gap
- +574.8%
- Target range width
- 306.7%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MediciNova?
MediciNova has a verified none consensus. The same dataset has an average price target of $9.00.
How far are MediciNova's low and high targets from the recorded price?
The low target implies +268.1%, while the high target implies +574.8%.
How many analysts are included in MediciNova's consensus?
The verified consensus includes 3 analysts.
How is MediciNova's target upside or downside calculated?
The average target of $9.00 is divided by the recorded price of $1.63, then one is subtracted to produce +452.1%. This does not guarantee a future return.
When was MediciNova's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.